1,737
Views
93
CrossRef citations to date
0
Altmetric
Review

Functional diversity of SDF-1 splicing variants

Pages 243-249 | Received 08 Jan 2009, Accepted 23 Feb 2009, Published online: 01 Jul 2009

Figures & data

Figure 1 Splicing variant-dependent susceptibility to the degradation process of SDF-1 in blood. Large squares correspond to the ordered structure of the protein. Disordered ends are represented by thinner shapes. The regions of the protein resistant to proteolysis are marked in blue, while parts colored in red represent endings susceptible to the degradation process. The lowest row of words describes the contribution of particular exons to the final structure of the SDF-1 protein. The scissors symbolize the sites of proteinase attack. The large gray arrow in the center of the figure points to the phenomenon of C-terminus degradation prevention by an attachment of a fourth exon resistant to proteolysis during the splicing process.

Figure 1 Splicing variant-dependent susceptibility to the degradation process of SDF-1 in blood. Large squares correspond to the ordered structure of the protein. Disordered ends are represented by thinner shapes. The regions of the protein resistant to proteolysis are marked in blue, while parts colored in red represent endings susceptible to the degradation process. The lowest row of words describes the contribution of particular exons to the final structure of the SDF-1 protein. The scissors symbolize the sites of proteinase attack. The large gray arrow in the center of the figure points to the phenomenon of C-terminus degradation prevention by an attachment of a fourth exon resistant to proteolysis during the splicing process.

Figure 2 Splicing variant-dependent strength of SDF-1 binding to CXCR4 on the cell surface. The cell membrane is covered by negatively charged GAGs shown as blue spots. The active part of the SDF-1 molecule binding to the receptor is marked in green. Red shapes represent the positively charged part of the SDF-1 molecule stabilizing the process of receptor activation through their interaction with the negatively charged GAGs. (A) The red oval reflects the “standard” positive charge characteristic of all SDF-1 molecules. It is similar for SDF-1α and SDF-1β and is strong enough only for short term receptor binding. Thus, only a limited number of SDF-1 molecules interact with the receptor at the same time, while most of them are in an unbound state. (B) In contrast, the addition of a long, strongly positively charged product of the fourth exon in the case of the SDF-1γ isoform, which is represented in the figure by a “tail” of red spots, facilitates a very strong and long-term stabilization of SDF-1 binding to CXCR4. It results in the persistency of SDF-1 activity which is shown by widespread binding of the SDF-1 molecule to its cognate receptor.

Figure 2 Splicing variant-dependent strength of SDF-1 binding to CXCR4 on the cell surface. The cell membrane is covered by negatively charged GAGs shown as blue spots. The active part of the SDF-1 molecule binding to the receptor is marked in green. Red shapes represent the positively charged part of the SDF-1 molecule stabilizing the process of receptor activation through their interaction with the negatively charged GAGs. (A) The red oval reflects the “standard” positive charge characteristic of all SDF-1 molecules. It is similar for SDF-1α and SDF-1β and is strong enough only for short term receptor binding. Thus, only a limited number of SDF-1 molecules interact with the receptor at the same time, while most of them are in an unbound state. (B) In contrast, the addition of a long, strongly positively charged product of the fourth exon in the case of the SDF-1γ isoform, which is represented in the figure by a “tail” of red spots, facilitates a very strong and long-term stabilization of SDF-1 binding to CXCR4. It results in the persistency of SDF-1 activity which is shown by widespread binding of the SDF-1 molecule to its cognate receptor.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.